[go: up one dir, main page]

AU2001258117A1 - Supports for photosensitizer formulations - Google Patents

Supports for photosensitizer formulations

Info

Publication number
AU2001258117A1
AU2001258117A1 AU2001258117A AU5811701A AU2001258117A1 AU 2001258117 A1 AU2001258117 A1 AU 2001258117A1 AU 2001258117 A AU2001258117 A AU 2001258117A AU 5811701 A AU5811701 A AU 5811701A AU 2001258117 A1 AU2001258117 A1 AU 2001258117A1
Authority
AU
Australia
Prior art keywords
supports
photosensitizer formulations
photosensitizer
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258117A
Inventor
Rubinah Kausar Chowdhary
David H. Dolphin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU2001258117A1 publication Critical patent/AU2001258117A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001258117A 2000-05-08 2001-05-08 Supports for photosensitizer formulations Abandoned AU2001258117A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20264000P 2000-05-08 2000-05-08
US60/202,640 2000-05-08
PCT/CA2001/000667 WO2001085213A2 (en) 2000-05-08 2001-05-08 Supports for photosensitizer formulations

Publications (1)

Publication Number Publication Date
AU2001258117A1 true AU2001258117A1 (en) 2001-11-20

Family

ID=22750712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258117A Abandoned AU2001258117A1 (en) 2000-05-08 2001-05-08 Supports for photosensitizer formulations

Country Status (4)

Country Link
US (1) US7282215B2 (en)
AU (1) AU2001258117A1 (en)
CA (1) CA2408332C (en)
WO (1) WO2001085213A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999005167A1 (en) * 1997-07-25 1999-02-04 University Of Massachusetts Designed protein pores as components for biosensors
WO2001085212A2 (en) * 2000-05-08 2001-11-15 The University Of British Columbia Drug delivery systems for photodynamic therapy
AT408835B8 (en) * 2000-05-23 2002-07-25 Andreas Dipl Ing Dr Kubin PREPARATION OF HYPERICIN TIED TO POLYVINYLPYRROLIDONE (PVP) DIFFERENT GRADES OF POLYMERIZATION AND CROSSLINKING
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
AU2007202603B2 (en) * 2001-04-11 2010-06-10 Valeant Pharmaceuticals International, Inc. Drug delivery system for hydrophobic drugs
GB0113121D0 (en) * 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
WO2003039597A1 (en) 2001-11-09 2003-05-15 Qlt Inc. Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
DE10222738A1 (en) * 2002-05-23 2003-12-11 Johannes Wohlrab Photodynamic therapy of epithelial and/or non-epithelial tumors or psoriasis, using UV-light in presence of topically and/or systemically administered ketoprofen as photosensitizer
US20040010218A1 (en) * 2002-07-11 2004-01-15 Henderson Barbara W. Photodynamic therapy for the enhancement of vascular permeability to aid in drug delivery to diseased tissues
US20040045546A1 (en) * 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
US20100100030A1 (en) * 2002-09-12 2010-04-22 Ceramoptec Industries Inc. Microbe Reductions with Photosensitizers
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
US7351749B2 (en) * 2002-12-16 2008-04-01 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Process for manufacture of personal care products utilizing a concentrate water phase
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
JP2008534670A (en) * 2005-04-07 2008-08-28 フォト・ダイアグノスティック・デバイシィズ・（ピーディーディー）・リミテッド Photosensitizer and MRI sensitizer
US8999933B2 (en) * 2006-01-18 2015-04-07 Biolitec Pharma Marketing Ltd Photodynamic cosmetic procedure and healing method
TWI461225B (en) * 2006-05-10 2014-11-21 Biolitec Pharma Marketing Ltd Photosensitizer formulations for topical applications
EP2051699B1 (en) * 2006-05-10 2018-09-26 biolitec Unternehmensbeteiligungs II AG Photosensitizer formulations for topical applications
US8858989B2 (en) * 2006-05-18 2014-10-14 Biolitec Pharma Marketing Ltd Gel-formulations of hydrophobic photosensitizers for mucosal applications
GB0702092D0 (en) * 2007-02-02 2007-03-14 Fracture Code Corp Aps Graphic Code Application Apparatus and Method
US8709473B1 (en) * 2009-01-28 2014-04-29 Abbott Cardiovascular Systems Inc. Method of targeting hydrophobic drugs to vascular lesions
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
US20120101427A1 (en) * 2009-04-28 2012-04-26 Gerard Farmer Novel photosensitizer formulations for oral administration
US20100310660A1 (en) * 2009-06-08 2010-12-09 Taipei Medical University Dry powder microparticles for pulmonary delivery
SG185094A1 (en) 2010-04-30 2012-12-28 Prostetta Antiviral Inc Antiviral compounds
US8828986B2 (en) 2011-04-20 2014-09-09 Prosetta Antiviral Inc. Antiviral compounds
EP3083491A1 (en) * 2013-12-16 2016-10-26 Council of Scientific and Industrial Research Functionalized zinc oxide nanoparticles for photocatalytic water splitting
US10918719B2 (en) * 2014-02-28 2021-02-16 Massachusetts Eye And Ear Infirmary Methods for cross-linking corneal collagen with verteporfin for the treatment of disorders of the eye
RU184518U1 (en) * 2017-01-27 2018-10-30 Виктор Филиппович Агафонников Gastrointestinal electrostimulator with endogenous vanadium iontophoresis
CN113616811B (en) * 2021-08-18 2023-12-05 南京中医药大学 An apolipoprotein-modified fusion multifunctional nanovesicle and its preparation method and application
CN117981830B (en) * 2024-02-02 2025-02-07 广州绿徽新材料研究院有限公司 A composition

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125503A (en) * 1976-10-12 1978-11-14 Mobil Oil Corporation Ultraviolet curing emulsion systems
CH621479A5 (en) * 1977-08-05 1981-02-13 Battelle Memorial Institute
US4744989A (en) 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
GB8613811D0 (en) 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US5171749A (en) 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5283255A (en) 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5096629A (en) 1988-08-29 1992-03-17 501 Nippon Fine Chemical Co., Ltd. Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
US5171741A (en) 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5173504A (en) 1989-04-21 1992-12-22 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5308608A (en) 1989-06-07 1994-05-03 University Of British Columbia Photosensitizing Diels-Alder porphyrin derivatives
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
US5186100A (en) 1992-01-16 1993-02-16 Sequa Corporation Interchangeable inker having enclosed transmission
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
US5674468A (en) * 1992-03-06 1997-10-07 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
US5726304A (en) 1992-10-30 1998-03-10 The University Of British Columbia Porphocyanine and CNC-expanded porphyrins
US5405957A (en) 1992-10-30 1995-04-11 The University Of British Columbia Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use
US5648485A (en) 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US5703230A (en) 1994-12-02 1997-12-30 University Of British Columbia Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5885557A (en) * 1996-02-08 1999-03-23 Estee Lauder Inc. Compositions useful in the phototherapeutic treatment of proliferative skin disorders
WO1999013943A1 (en) * 1996-03-05 1999-03-25 Ekos Corporation Ultrasound assembly for use with light activated drugs
US5883246A (en) 1996-03-07 1999-03-16 Qlt Phototherapeutics, Inc. Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
US6015576A (en) * 1997-08-29 2000-01-18 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to an antigen
WO1997035559A2 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Manufacture of liposomes and lipid-protein complexes by ethanolic injection and thin film evaporation
US6375930B2 (en) * 1996-06-04 2002-04-23 Board Of Regents, The University Of Texas System Membrane incorporation of texaphyrins
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
WO1998050387A1 (en) 1997-05-07 1998-11-12 Qlt Phototherapeutics, Inc. Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
US5880145A (en) 1997-05-07 1999-03-09 The University Of British Columbia Class of benzoporphyrin derivative photoactive compounds
GB9721367D0 (en) 1997-10-09 1997-12-10 Univ Liverpool Delivery system
ATE296113T1 (en) * 1998-02-09 2005-06-15 Bracco Research Sa TARGETED RELEASE OF BIOLOGICAL-ACTIVE MEDIA
US5939453A (en) * 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6916488B1 (en) 1999-11-05 2005-07-12 Biocure, Inc. Amphiphilic polymeric vesicles
WO2001085212A2 (en) * 2000-05-08 2001-11-15 The University Of British Columbia Drug delivery systems for photodynamic therapy
US6338859B1 (en) * 2000-06-29 2002-01-15 Labopharm Inc. Polymeric micelle compositions

Also Published As

Publication number Publication date
CA2408332A1 (en) 2001-11-15
US20020061330A1 (en) 2002-05-23
US7282215B2 (en) 2007-10-16
WO2001085213A3 (en) 2002-08-01
WO2001085213A2 (en) 2001-11-15
CA2408332C (en) 2011-02-15

Similar Documents

Publication Publication Date Title
AU2001258117A1 (en) Supports for photosensitizer formulations
AU2002222853A1 (en) Therapeutic compounds
AU2001259690A1 (en) Approach for generating rules
AU2001252135A1 (en) Therapeutic agents
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU3198200A (en) Prrsv vaccines
AUPQ441699A0 (en) Pour-on formulations
AU2001230537A1 (en) Pyridoxazine derivatives
AU4439701A (en) Patient support
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001263839A1 (en) Liquid formulations
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU4430701A (en) Compounds for targeting
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU5256301A (en) Froindazole derivative
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001220281A1 (en) Rollerboard for road-skiing
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives